Selection of blockbuster announcements

1、$China Petroleum & Chemical Corporation (00386.HK) $Sell part of Secco's shares to strategic investors

China Petroleum & Chemical Corporation (00386) issued an announcement, and the meeting of the board of directors examined and passed the motion, agreed to transfer 15% and 35% of the shares of Shanghai Secco Petrochemical Co., Ltd. (Secco) held by China Petroleum & Chemical Shanghai Gaoqiao Petrochemical Co., Ltd. (hereinafter referred to as "Gaoqiao Petrochemical Company") respectively on the Shanghai United property Exchange. With reference to Secco's net assets valuation (which still needs to go through the filing procedure), the reserve price for listing is initially determined to be 10.307 billion yuan.

2、$Geely Automobile (00175.HK) $Total car sales rose 2 per cent year-on-year to about 78500 units in February

Geely Automobile (00175) announced that the group's total sales in February 2022 was 78478, an increase of about 2% over the same period last year, but a decrease of about 46% compared with January 2022, mainly affected by the shortage of ESP chips and the Spring Festival holiday. In February 2022, the group's Lecker brand delivered 1188 vehicles to subscriber customers in the European market under an innovative subscription model, while a total of 2416 vehicles were delivered in the first two months of 2022.

3、$Guangzhou Automobile Group (02238.HK) $Car sales reached 143500 in February, up 163.23% from the same period last year.

Guangzhou Automobile Group (02238) announced that the company's car production in February 2022 was 151919, an increase of 46.16% over the same period last year; cumulative production in 2022 was 370532, an increase of 25.28% over the same period last year; car sales in February of 2022 were 143464, an increase of 36.47% over the same period last year; and cumulative sales in 2022 were 380696, an increase of 18.06%. Among them, GAC Ean New Energy sold 8526 vehicles in February 2022, up 163.23 percent from the same period last year, and accumulated sales of 24557 vehicles in 2022, an increase of 131.78 percent over the same period last year.

4、$Healthcare-B (02160.HK) $Registration of ALWIDE PLUS balloon catheter in Argentina

Xintong Medical-B (02160.HK) announced that the Alwide Plus balloon catheter independently developed by the company has been successfully registered in Argentina. Alwide Plus, the second-generation upgraded product of the company's Alwide balloon catheter, was approved by the State Drug Administration of China on July 29th, 2021.

Its main features include: (I) low compliance can achieve more accurate balloon dilatation size; (ii) high blasting pressure is suitable for lesions with severe calcification; (iii) rapid filling retraction can minimize pacing time. Compared with the first generation products, Alwide Plus is designed to increase the blasting pressure. The company believes that Alwide Plus can reduce the challenge of valvuloplasty in TAVI (transcatheter aortic valve implantation) surgery.

5、$NIO Inc.-SW (09866.HK) $It closed at $18.12 on the New York Stock Exchange on March 7.

NIO Inc.-SW (09866) announced that trading of Class A common shares on the Hong Kong Stock Exchange is expected to begin on March 10, 2022, and NIO Inc. American depositary shares closed at US $18.12 (HK $141.58) on the New York Stock Exchange on March 7, 2022.

6、$United (00486.HK) $Controlling shareholder En+ is considering the possibility of developing the company's international business.

United (00486) announced that the company took note of an article published by Bloomberg on March 4, 2022, claiming, among other things, that the company's controlling shareholder, EN+ GROUP International public joint-stock company (En+), had begun a strategic review of the company.

The company also notes that En+ issued a statement on this article on March 7, 2022, in which En+ confirmed that it is currently reviewing its strategy for the company. According to En+ 's statement, options under consideration include the possibility of expanding the company's international business. En+ stressed that the strategic review was at an early stage and that any future course of action would need to be further considered and discussed with relevant regulators and key stakeholders.

Important matters

Genscript Biotech Corporation (01548): legendary America signs a temporary product supply agreement with Janssen

The first class 1 macromolecular innovative drug HER2 double anti-XZP-KM257 attached to Sihuan Medicine (00460) has been approved to conduct clinical trials.

China Gold International (02099) ordinary shares have been successfully accepted as eligible trading shares for Shenzhen-Hong Kong Stock Connect.

Kangfang Bio-B (09926): II phase clinical approval of cardunil combined with docetaxel in the treatment of advanced NSCLC treated with PD-1 / L1

Financial report data

Chizi City Science and Technology (09911) expects the adjusted net profit to increase by nearly 100% year on year in 2021 to reach 300-320 million yuan.

Huabao International (00336) expects annual net profit to rise by about 24% to 39%.

Tomson Group (00258) Yingxi: 60% increase in annual after-tax comprehensive profit

China Ruyi (00136) expects the net profit in 2021 to be about 92 to 100 times that of 2020, reaching 11 to 1.2 billion yuan.

SITC International Holdings (01308) profit attributable to shareholders in 2021 increased by about 2.31 times year-on-year to a final dividend of HK140 cents per share of US $1.163 billion.

Levin Chemical (00746) profit in 2021 increased by about 1.56 times to HK $1.288 billion final interest of HK32 cents per share

Yueda International Holdings (00629) expects comprehensive profit and total comprehensive income to grow by 40% in 2021 compared with the same period last year.

Total contract sales of Jianye Real Estate (00832) in the first two months increased by 35.5% to 3.165 billion yuan compared with the same period last year.

Profit attributable to equity holders of AsiaInfo Technology (01675) increased by 18.67% to 785 million yuan in 2021.

The profit after tax of Yuexiu Real Estate Trust Fund (00405) increased by 14.9% to 675 million yuan compared with the same period last year.

Annual profit attributable to shareholders of Hong Kong Shengli Beer (00236) increased by 12.4% to HK $19.364 million compared with the same period last year.

Power generation of Xiehe New Energy (00182) increased 2.06% to 947.76GWh in the first two months compared with the same period last year.

Sales volume increases sharply (03302) expected annual net profit after tax is about S $12.6 million

Cosco Group (03377) agreed sales of about 8.22 billion yuan in the first two months.

The total contract sales of Hopson Development (00754) in the first two months was 4.945 billion yuan.

Poly Real Estate Group (00119) February contract sales of 1.4 billion yuan

Turn losses into profits and prolong the expected annual profit of Petroleum International (00346) of about HK $358 million

Lyle Stein (00738) expects the profit attributable to shareholders to be 1 million-3 million yuan in 2021.

The loss attributable to shareholders of Gaopeng Mining (02212) decreased by 78.82% compared with the same period last year.

Madi Weikang (02159) annual comprehensive net profit is reduced by 78%

Liwen Paper (02314) profit attributable to shareholders in 2021 decreased by 11.38% year on year to HK $3.123 billion final dividend of HK $0.11 per share.

Ming Yuan Cloud Group (00909) expects the loss attributable to shareholders to be about 310 million yuan to 360 million yuan.

Profit and loss Weiye Holdings (01570) expected annual loss attributable to shareholders 135 million yuan

Or profit to loss Xinshi Culture (01740) annual loss of 38 million to 45 million yuan

ALCO HOLDINGS (00328) expects annual net loss to increase compared with the same period last year.

Repurchase cancellation

China Gas (00384) HK $248 million buyback 20.788 million shares on March 7

HSBC Holdings PLC (00005) buys back about 9.7452 million shares on March 7th.

Bond bill

Bank of China Ltd. (03988): the $400m note is expected to be listed on March 8th.

Change of equity

China Telecom Corporation (00728): China Telecom Corporation Group accumulatively increased its holdings of 467 million A shares

Junshi Bio (01877) proposes to issue no more than 70 million A shares

Shenzhen Expressway (00548) intends to sell 51% of Yanjiang company to Bay area Development.

South China Finance (00619) sold 7 million shares of China Petroleum & Chemical Corp Petroleum (01033) H shares for HK $5.1 million

Asset acquisition

21st Century Education (01598) affiliated 56.05 million yuan to acquire land use rights in Gaoyi County, Shijiazhuang

The subsidiary of Shi Si Pharmaceutical Group (02005) signed a letter of intent to acquire the entire stake in Cangzhou Lingang Friendship Chemical Industry.